Robin P. Garner

Safety and Immunogenicity of an HIV Subtype B and E Prime‐Boost Vaccine Combination in HIV‐Negative Thai Adults

Sorachai Nitayaphan, Punnee Pitisuttithum, Chitraporn Karnasuta et al. · The Journal of Infectious Diseases · 2004 · 136 citations · Full text

Immunology, Immunodominance, Immunotherapy +19

Mucosal Immune Responses in Four Distinct Compartments of Women Infected with Human Immunodeficiency Virus Type 1: A Comparison by Site and Correlation with Clinical Information

Andrew W. Artenstein, Thomas C. VanCott, Karl Sitz et al. · The Journal of Infectious Diseases · 1997 · 68 citations · Full text

Primary Immunodeficiency, Mucosal Sites, Autoimmune Disease +14

Safety and Immunogenicity of Combinations of Recombinant Subtype E and B Human Immunodeficiency Virus Type 1 Envelope Glycoprotein 120 Vaccines in Healthy Thai Adults

Punnee Pitisuttithum, Sorachai Nitayaphan, P Thongcharoen et al. · The Journal of Infectious Diseases · 2003 · 66 citations · Full text

Efficacy Testing of Recombinant Human Immunodeficiency Virus (HIV) gp160 as a Therapeutic Vaccine in Early‐Stage HIV‐1–Infected Volunteers

Deborah L. Birx, Lawrence D. Loomis‐Price, Naomi Aronson et al. · The Journal of Infectious Diseases · 2000 · 57 citations · Full text

Vaccination, Primary Immunodeficiency, Envelope Glycoprotein Gp160 +13

Repeated Immunization with Recombinant gp160 Human Immunodeficiency Virus (HIV) Envelope Protein in Early HIV‐1 Infection: Evaluation of the T Cell Proliferative Response

Silvia Ratto‐Kim, Karl Sitz, Robin P. Garner et al. · The Journal of Infectious Diseases · 1999 · 30 citations · Full text